Periostin-induced pancreatic regeneration

Details for Australian Patent Application No. 2009290091 (hide)

Owner Ottawa Hospital Research Institute

Inventors Rudnicki, Michael; Smid, Johnathan

Agent Griffith Hack

Pub. Number AU-A-2009290091

PCT Pub. Number WO2010/025555

Priority 61/095,176 08.09.08 US

Filing date 8 September 2009

Wipo publication date 11 March 2010

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

21 April 2011 PCT application entered the National Phase

  PCT publication WO2010/025555 Priority application(s): WO2010/025555

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009290093-Method of displaying applications in a multi-monitor computer system and multi-monitor computer system employing the method

2009290089-Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase